These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16110606)

  • 1. Anthracyclines.
    Hamilton D; Batist G
    Cancer Chemother Biol Response Modif; 2005; 22():19-33. PubMed ID: 16110606
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: anthracyclines in early-stage breast cancer: is it the end of an era?
    Pritchard KI
    Oncologist; 2009 Oct; 14(10):959-62. PubMed ID: 19819915
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancer.
    Morris PG; Bach PB
    Onkologie; 2009 Sep; 32(8-9):464-6. PubMed ID: 19745589
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment evaluation in active control studies.
    Fleming TR
    Cancer Treat Rep; 1987 Nov; 71(11):1061-5. PubMed ID: 3119201
    [No Abstract]   [Full Text] [Related]  

  • 6. "To the heart of the matter...".
    Kamen BA; Drachtman R
    Pediatr Hematol Oncol; 2000; 17(1):5-7. PubMed ID: 10689709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mitoxantrone--a new cytostatic agent].
    Klein HO
    Fortschr Med; 1985 Feb; 103(8):229-30. PubMed ID: 3979939
    [No Abstract]   [Full Text] [Related]  

  • 8. The alphabet soup of chemotherapy.
    Dinman S
    Plast Surg Nurs; 2007; 27(3):173-5. PubMed ID: 17901830
    [No Abstract]   [Full Text] [Related]  

  • 9. Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?
    Di Leo A; Biganzoli L; Claudino W; Licitra S; Pestrin M; Larsimont D
    Eur J Cancer; 2008 Dec; 44(18):2791-8. PubMed ID: 18993056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anthracyclines in adjuvant chemotherapy of breast cancer: a critical appraisal.
    Mouridsen HT
    Recent Results Cancer Res; 1996; 140():191-9. PubMed ID: 8787062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Green urine].
    Sauter C
    Schweiz Med Wochenschr; 1998 Dec; 128(50):2003. PubMed ID: 9888172
    [No Abstract]   [Full Text] [Related]  

  • 13. Anthracyclines in the treatment of HER2-negative breast cancer.
    Paik S; Taniyama Y; Geyer CE
    J Natl Cancer Inst; 2008 Jan; 100(1):2-4. PubMed ID: 18159066
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitozantrone--out of the blue.
    Smith G
    Aust Nurses J; 1989 Mar; 18(8):28. PubMed ID: 2730451
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticancer agents and cardiotoxicity.
    Ng R; Better N; Green MD
    Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracyclines.
    Gianni L; Grasselli G; Cresta S; Locatelli A; Viganò L; Minotti G
    Cancer Chemother Biol Response Modif; 2003; 21():29-40. PubMed ID: 15338739
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity during monochemotherapy with mitoxantrone: preliminary results.
    Cartei G; Contessi E; Comelli M; Turrin D; Toso C; Sibau A; Mian S; Bramezza M
    J Chemother; 1989 Jul; 1(4 Suppl):1309-10. PubMed ID: 16312879
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukaemia due to mitoxantrone.
    Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
    Mehta RS; Schubbert T
    J Natl Cancer Inst; 2008 May; 100(9):680; author reply 680-1. PubMed ID: 18445822
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitoxantrone: a promising new chemotherapeutic agent.
    Dalton WS; Alberts DS
    Ariz Med; 1984 Feb; 41(2):96-8. PubMed ID: 6703919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.